Supplementary Figures
Supplementary Figure 1 . General diagram of data and workflow for this study. Whole-genome sequencing of tumor-blood pairs from 92 cases (57 lung AD and 35 lung SCC) was performed. The transcriptome sequences were analyzed in 90 of 92 patients. Additional whole-exome sequencing on 57 pairs (27 lung AD and 30 lung SCC) was used to study exonic mutations. a. The data involved in this study; b. The analysis and results in this study. Supplementary Figure 2 . a. Mutation (substitutions and indels) rates identified in the whole-exome sequences data from Chinese NSCLC patients; b. Whole genome distribution of copy number alterations identified using whole-genome sequences data. Red indicates amplifications, and blue indicates deletions. The annotated genes were potential driver genes located in the regions with significantly altered copy numbers detected by GISTIC2. Wilcoxon rank sum test was used to evaluate the differences.
Supplementary Figure 5 . a. The fusions involving BCAR4 occurred in one our patient and one TCGA patient. The expression of exons retained in the putative fusion transcript was relatively higher than the expression of exons not in the putative fusion transcript (as indicated by the gray box). b. The expression of BCAR4 was highly activated in our patient. c. The expression of ERBB3 was highly activated in our patient. 
Supplementary Tables
Supplementary Table 1 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2(0.4) n/a WGS: whole genome sequencing; WES: whole exome sequencing; Lung AD: lung adenocarcinoma; Lung SCC: lung squamous cell carcinoma.
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